Table 3.
Results of the mixed logistic regression predicting for which cases no recommendation was given (N = 249 cases in 29 sessions)
| Predictor | Full model | Stepwise model | ||||
|---|---|---|---|---|---|---|
| OR | 95% CI | P | OR | 95% CI | P | |
| Dermatological vs. gyn. MDTM | 2.22 | 0.09 to 57.79 | .629 | |||
| Gastrointestinal vs. gyn. MDTM | 0.40 | 0.01 to 16.15 | .625 | |||
| Head and neck cancer vs. gyn. MDTM | 1.60 | 0.36 to 7.07 | .534 | |||
| Liver and biliary tract vs. gyn. MDTM | 4.81 | 1.10 to 20.98 | .037** | 4.41 | 1.38 to 14.11 | .013** |
| Lymphoma and myeloma vs. gyn. MDTM | 3.10 | 0.25 to 37.91 | .373 | 6.62 | 0.81 to 53.85 | .077* |
| Neuro-oncological vs. gyn. MDTM | 1.99 | 0.20 to 20.10 | .559 | |||
| Non-entity-specific oncological vs. gyn. MDTM | 0.39 | 0.02 to 6.09 | .497 | |||
| Non-entity-specific surgical vs. gyn. MDTM | 2.64 | 0.39 to 17.86 | .319 | 3.48 | 0.80 to 15.15 | .096* |
| Thorax vs. gyn. MDTM | 7.89 | 0.57 to 109.22. | .123 | 9.48 | 0.98 to 92.02 | .052** |
| Uro-oncological vs. gyn. MDTM | 3.13 | 0.23 to 43.50 | .395 | 9.40 | 1.13 to 78.25 | .038** |
| Number of attending professionals (1 person increase) | 1.05 | 0.94 to 1.18 | .385 | |||
| Duration of session (10 min increase) | 1.97 | 1.09 to 3.58 | .024** | 1.32 | 0.98 to 1.76 | .071* |
| Number of cases discussed in this session (1 case increase) | 0.81 | 0.62 to 1.05 | .111 | |||
| Quality of case historya | 0.36 | 0.15 to 0.84 | .019** | 0.30 | 0.13 to 0.68 | .004** |
| Quality of radiological informationa | 0.74 | 0.54 to 1.02 | .063* | 0.68 | 0.51 to 0.90 | .008** |
| Quality of information on comorbiditiesa | 0.85 | 0.66 to 1.11 | .226 | |||
| Presentation of whether case was palliative (dichotomous variable) | 1.06 | 0.36 to 3.13 | .910 | |||
| Quality of psychosocial informationa | 1.08 | 0.76 to 1.53 | .686 | |||
| Quality of information on the patient’s views and preferencesa | 0.91 | 0.64 to 1.30 | .614 | |||
| Number of active participants in the discussion of each individual case (1 person increase) | 0.94 | 0.73 to 1.21 | .605 | |||
| Quality of chair behaviora | 0.79 | 0.54 to 1.17 | .237 | |||
| Quality of team behaviora | 0.97 | 0.60 to 1.55 | .884 | |||
| Medical and treatment uncertainty during case discussiona | 1.10 | 0.85 to 1.42 | .459 | |||
| Duration of case discussion (1 min increase) | 1.13 | 0.94 to 1.27 | .154 | 1.13 | 1.00 to 1.27 | .067* |
OR Odds ratio, CI Confidence interval, gyn gynecological
Bold typesetting of OR indicates statistical significance
*Indicates p < .10
**Indicates p < .05
aIndicates 1 step increase